Cutis; cutaneous medicine for the practitioner 1983-05-01

Comparison of amcinonide ointment 0.1 percent twice daily and fluocinonide ointment 0.05 percent three times daily in the treatment of psoriasis.

R C Cornell

Index: Cutis. 31(5) , 566-9, (1983)

Full Text: HTML

Abstract

Thirty-nine patients with psoriasis were treated either with amcinonide ointment 0.1 percent twice a day or with fluocinonide ointment 0.05 percent three times a day in a two-week, randomized, parallel-group, double-blind study. The severities of the skin lesions at baseline and at weekly intervals and the overall improvement at weekly intervals were evaluated by the investigator and the patient. The skin lesions improved significantly (p less than or equal to 0.01) over their condition at baseline, with good overall improvement attained by both treatment groups within one week. Both treatments were well tolerated. Amcinonide ointment 0.1 percent applied twice a day was found to be as effective and acceptable to patients as was fluocinonide ointment 0.05 percent applied three times a day in the treatment of psoriasis.


Related Compounds

Related Articles:

Contact allergy to amcinonide.

1986-08-01

[Contact Dermatitis 15(2) , 109-11, (1986)]

Trypsin inhibitors inhibit induction by interferon-gamma of HLA-DR antigen expression on human skin cells.

1989-07-01

[Exp. Cell Res. 183(1) , 215-28, (1989)]

Selective corticosteroid injection into the extensor pollicis brevis tenosynovium for de Quervain's disease.

2002-01-01

[Orthopedics 25(1) , 68-70, (2002)]

Perioral dermatitis secondary to the use of a corticosteroid ointment as mustache wax.

1987-12-01

[Int. J. Dermatol. 26(10) , 649, (1987)]

Identification and characterization of triamcinolone acetonide, a microglial-activation inhibitor.

2012-12-01

[Immunopharmacol. Immunotoxicol. 34(6) , 912-8, (2012)]

More Articles...